Rathod, S., McManus, D., Rivera-Vinas, J., Topal, J. E., & Martinello, R. A. (2019). 2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime. Open Forum Infect Dis.
Citação norma ChicagoRathod, Shardul, Dayna McManus, Jose Rivera-Vinas, Jeffrey E. Topal, and Richard A. Martinello. "2385. Evaluating the Antibiotic Risk for Clostridioides Difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime." Open Forum Infect Dis 2019.
Citação norma MLARathod, Shardul, et al. "2385. Evaluating the Antibiotic Risk for Clostridioides Difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime." Open Forum Infect Dis 2019.